Patents by Inventor G. Andrew Franz

G. Andrew Franz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030191185
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: October 9, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Non-granulated levothyroxine pharmaceutical compositions
    Publication number: 20030185885
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 10, 2002
    Publication date: October 2, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030181524
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: September 25, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Stabilized pharmaceutical compositions
    Publication number: 20030180353
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 10, 2002
    Publication date: September 25, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030180356
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: September 25, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030175337
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: September 18, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030171436
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: September 11, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030165564
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: September 4, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
    Publication number: 20030119911
    Abstract: A pharmaceutical composition with &bgr;-sheet microcrystalline cellulose with improved potency life and methods of preparation therefor. Improved thyroid hormone pharmaceutical compositions comprising 50 weight % or more of &bgr;-sheet microcrystalline cellulose.
    Type: Application
    Filed: February 15, 2002
    Publication date: June 26, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions and methods
    Patent number: 6555581
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: April 29, 2003
    Assignee: Jones Pharma, Inc.
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Manufacture of thyroid hormone tablets having consistent active moiety amounts
    Publication number: 20030032675
    Abstract: An apparatus for the transport of thyroid hormone drug formulations from a blender to a tablet press using mass flow of the formulation in order to maintain consistent tablet compositions during manufacture of the tablets.
    Type: Application
    Filed: February 15, 2002
    Publication date: February 13, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma, Matthew Smith, Scott C. Vaaler, Floyd Meredith